Overview

Study for the Use of Alteplase in Patients Who Awaken With Stroke

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a pilot study of thrombolytic therapy in patients with ischemic stroke who present with stroke symptoms upon awakening.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, San Diego
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Scripps Health
Treatments:
Tissue Plasminogen Activator